Neurodegenerative diseases affect more than 57 million people globally. The incidence of these diseases, from Alzheimer's to Parkinson's to ALS and beyond, is expected to double every 20 years. Though ...

Neurodegenerative diseases affect more than 57 million people globally. The incidence of these diseases, from Alzheimer's to ...

A new AI-assisted brain atlas that can help visualize the human brain in unprecedented detail has been developed by UCL researchers, in a major step forward for neuroscience and neuroimaging. The ...

Recently, a neuroimaging study funded by the European Research Council introduced “NextBrain,” a three-dimensional, probabilistic, high-resolution brain atlas that maps the brain into 333 regions to ...

One in three Americans is likely to be affected by a brain disorder in their lifetime. Many of these conditions, such as Alzheimer's disease or severe developmental disorders, have no reliable ...

A new AI-assisted brain atlas that can help visualize the human brain in unprecedented detail has been developed by UCL researchers, in a major step forward for neuroscience and neuroimaging. The ...

A new 3D 'atlas' of the mouse brain promises to sharpen scientists' ability to measure brain changes and share findings across studies of diseases like Alzheimer's. The mouse brain atlas combines ...

Researchers at Duke-NUS Medical School have developed a detailed single-cell atlas of the developing human brain, offering a new reference point for evaluating lab-grown neurons used in Parkinson’s ...

Brain growth and maturation doesn't progress in a linear, stepwise fashion. Instead, it's a dynamic, choreographed sequence that shifts in response to genetics and external stimuli like sight and ...

The drugs have names that sound like small planets: semaglutide, liraglutide, lixisenatide. Collectively, they belong to a class of glucagon-like peptide 1 (GLP-1) analogs that has reshaped the ...